Cargando…
Contemporary Primary Prevention Aspirin Use by Cardiovascular Disease Risk: Impact of US Preventive Services Task Force Recommendations, 2007—2015: A Serial, Cross‐sectional Study
BACKGROUND: No previous study has evaluated the impact of past US Preventive Services Task Force statements on primary prevention (PP) aspirin use in a primary care setting. The aim of this study was to evaluate temporal changes in PP aspirin use in a primary care population, stratifying patients by...
Autores principales: | Van't Hof, Jeremy R., Duval, Sue, Walts, Adrienne, Kopecky, Stephen L., Luepker, Russell V., Hirsch, Alan T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721844/ https://www.ncbi.nlm.nih.gov/pubmed/28974502 http://dx.doi.org/10.1161/JAHA.117.006328 |
Ejemplares similares
-
Association of a Community Population and Clinic Education Intervention Program With Guideline-Based Aspirin Use for Primary Prevention of Cardiovascular Disease: A Nonrandomized Controlled Trial
por: Luepker, Russell V., et al.
Publicado: (2022) -
Cost‐Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease
por: Michaud, Tzeyu L., et al.
Publicado: (2015) -
Population Trends in Aspirin Use for Cardiovascular Disease Prevention 1980–2009: The Minnesota Heart Survey
por: Luepker, Russell V., et al.
Publicado: (2015) -
Estimation of Cardiovascular Risk from Self-Reported Knowledge of Risk Factors: Insights from the Minnesota Heart Survey
por: Duval, Sue, et al.
Publicado: (2020) -
A 16-Month Community-Based Intervention to Increase Aspirin Use for Primary Prevention of Cardiovascular Disease
por: Oldenburg, Niki C., et al.
Publicado: (2014)